Deepwise, an innovative leader in the field of artificial intelligence and medical imaging solutions, has successfully raised an impressive $69 million in its latest funding round. Based in Beijing's Zhongguancun tech hub and with a branch in Hangzhou's AI Town, Deepwise is dedicated to enhancing healthcare services through cutting-edge deep learning technologies and proprietary algorithms. Founded in 2017 from the Artificial Intelligence Innovation Center at Peking University, the company focuses on supporting various medical institutions—ranging from hospitals to imaging centers—by providing sophisticated solutions powered by big data and internet-enabled healthcare applications.
The funds raised will be strategically utilized to further develop their state-of-the-art algorithmic systems, which are designed to support early detection and accurate diagnosis of malignant diseases, placing them at the forefront of the industry. With a commitment to improving primary healthcare infrastructure and implementing tiered diagnosis systems, Deepwise integrates internet technology with deep learning to create cloud-based imaging solutions that streamline remote diagnostics and consultations. This effort not only enhances efficiency but also democratizes access to high-quality medical care, fulfilling the company's social responsibility goals.
Deepwise is fueled by an exceptional research and development team comprised of scholars from prestigious institutions such as Stanford University and the Chinese Academy of Sciences, collaborating closely with top-tier medical organizations across the country. With this new capital injection, Deepwise aims to refine its solutions and continue its mission of making healthcare more accessible and efficient for all, revolutionizing the medical field and ensuring that healthcare delivery is no longer a challenge.
